Alacris, GSK sign deal to apply ModCell system in cancer research
Max Planck Institute for Molecular Genetics developed the ModCell system and licensed it to Alacris. GSK will provide pre-clinical biology data from oncology research to Alacris, which will
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.